Metahexamide

Metahexamide is a barbiturate sedative drug used to treat anxiety, insomnia, and seizures. It is sold under the brand name Mebaral and is also used as an anticonvulsant. Metahexamide works by slowing down the activity of the central nervous system, resulting in a calming effect. It is usually taken orally, usually in tablet form, but can also be taken rectally or intravenously. The effects of Metahexamide can last for several hours. Common side effects include drowsiness, dizziness, lightheadedness, confusion, and difficulty concentrating.

Metahexamide is a medication that was previously used to treat type 2 diabetes, but it is no longer commonly prescribed. Here's a breakdown of its key points:

Function:

  • Lowers blood sugar levels by stimulating the pancreas to release insulin.
  • Classified as a sulfonylurea, a class of drugs that work in this way.

Reason for Limited Use:

  • There are several reasons why metahexamide is not widely used anymore:
    • More effective medications: Newer medications for type 2 diabetes, such as metformin and DPP-4 inhibitors, are generally considered more effective and have a lower risk of side effects.
    • Increased risk of hypoglycemia: Metahexamide can cause hypoglycemia (low blood sugar), which can be dangerous.
    • Potential for serious side effects: In rare cases, it can lead to severe liver problems.

Current Use:

  • Due to the availability of safer and more effective medications, metahexamide is rarely prescribed nowadays.
Anatomical Therapeutic Chemical Classification
A - Alimentary tract and metabolism
A10 Drugs used in diabetes
A10B - Blood glucose lowering drugs, excluding insulins
A10BB Sulfonylureas
External Links